Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells - Wikidata - awgldk - TriplyDB

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

http://www.wikidata.org/entity/Q56964366

about

Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality The role of alpha(v)beta(3) in prostate cancer progression Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension.Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential Osteopontin: roles in implantation and placentation.Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype.Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves.Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing.Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.Osteopontin: a leading candidate adhesion molecule for implantation in pigs and sheep.Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus.Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium Skeleton and glucose metabolism: a bone-pancreas loop.Apoptotic cues from the extracellular matrix: regulators of angiogenesis.(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.Polymorphisms in three genes are associated with hemorrhagic stroke.Immunoregulation of bone remodelling Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.Periodontitis and rheumatoid arthritis: a review.Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice.Osteoprotegerin as a marker of atherosclerosis in diabetic patients.The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.Osteoimmunology.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Biomarkers associated with pulse pressure in African-Americans and non-Hispanic whites.Expression and regulation of osteoprotegerin in adipose tissue.Vitamin D status in gastrointestinal and liver disease.Endothelial progenitor cells for cancer gene therapy.Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact.Osteoprotegerin, vascular calcification and atherosclerosis.Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis.RANKL inhibition for the management of patients with benign metabolic bone disorders.Abdominal aortic aneurysm: a review of the genetic basis.The role of osteoprotegerin in cardiovascular disease.Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature.Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.

P2860

Q24623768-E5B48F3A-78C2-4E46-9607-0F19DFAB82D3 Q24682923-397D90FC-E8CD-4B46-9492-F683DD6AAB15 Q30477731-61740C84-90D8-4D33-AEDD-BA9205C945B0 Q33615922-22A48025-79B2-4582-B489-C3C0470AC0B3 Q34218572-15262E8C-204B-4163-A2F2-0BCB6BA6FB00 Q34318454-7AA41B88-B1D5-4268-B889-B3047652C6AC Q34555532-112B3DBB-88F2-4851-BB60-28B02E3A3EF6 Q34670503-11C12389-04B1-4753-99B4-FC67E17D5D05 Q34828137-FCF893A9-6800-47A8-A222-50E92FBBA55E Q34950497-5BDEC69E-4F53-4319-B02B-FB08FB037733 Q35066125-BD19C3AC-20A6-46B6-90E0-D53B7E2EBCE7 Q35175707-E4C923F2-CC63-40D8-A163-6E5C5028A714 Q35185705-A78F9EA4-658B-442D-96B6-E35B6DF43D56 Q35218871-179C9620-5202-4438-BDFC-81B6CDB96335 Q35250223-82896139-F49F-4ED4-B38D-5FFD0B87110B Q35603378-1535515D-7372-462D-A98E-3BEC66F5FB95 Q35620276-1E1EF8EF-D2D7-4DBB-9806-FC23545D4A8C Q35868148-9FD1E182-6D50-40F0-BD34-58C4A215E18B Q36107934-2A309B00-3809-4A1E-922B-9624AA1BC3D3 Q36248821-E5D7ABC1-7E39-4552-A379-792E0AF5E3FD Q36309246-897DDFD2-2B97-4A68-8592-6A1EE90E0724 Q36340848-590DDBC6-0CD2-436C-AB9F-84D4948E42F3 Q36530849-4E29DD78-3E88-4F9D-B7A1-43F4DF6D0FF1 Q36582644-34AFE60E-1F9E-40A9-BCFA-862E292BCA36 Q36686037-C3F949C6-85AD-4456-8C9A-8AF4787E130C Q36693328-470B29E7-1383-4AA0-8545-05350554FA75 Q36860987-7C7C1B64-F1C1-4157-9774-DB17FA60F27E Q37000882-EF9E0479-091F-46C5-A6F5-7A1C7E3DAAF5 Q37065591-A774C661-A6DE-43AB-8C4A-71D3254A70F3 Q37095126-02DD82C0-34EB-43EA-B846-2D39555661A8 Q37120174-1F3431AC-5F16-497D-9EA2-7545195F0D8E Q37149062-CD1EE074-7163-4D05-8AFD-6B69EF107D50 Q37285702-3FB97DD0-F23A-4CBC-BB95-7BCA65DBA572 Q37310825-811A88E1-6245-47E7-A3EC-7D0BE5858251 Q37418199-3DEF02F5-F519-4DF0-8469-10FF88BAD523 Q37532561-BCB75467-D120-4DD6-A349-B21FAC4D1771 Q37766689-C816D69A-E3E1-4BAE-B50F-B4EA78BBAE75 Q38056541-83BDDAA0-71B9-4540-B511-28D3757AB60D Q38120198-58B71B1C-D444-4FC2-945B-E2E2549C2EE1 Q38338847-262240C0-6CD8-4E9C-95BA-A2E193E379BA

P2860

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

http://www.wikidata.org/entity/Q56964366

description

article publié dans la revue scientifique Journal of Biological Chemistry

@fr

im Mai 2000 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Journal of Biological Chemistry

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2000

@uk

name

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

@en

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

@nl

type

label

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

@en

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

@nl

prefLabel

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

@en

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

@nl

P1433

Q56964366-5108CA99-CDFF-44B1-87C7-9C7AF4AE8EA4

P1476

Q56964366-AFD82FC8-B16F-45E9-9373-37BC49BD2C76

P2093

Q56964366-091E63C0-28CC-40C1-9B18-F15FEFA5CEE7

Q56964366-80D15741-7E5C-4C8D-8F72-D7A5EC27E642

Q56964366-B4BC41C3-35B8-44D5-A309-53260B935884

Q56964366-C811AAB8-1448-4761-866A-258702E30BCB

Q56964366-CACD379A-598D-4A03-B46B-CE7DC1B9FFBC

P2860

Q56964366-05A24950-9CA0-480D-9C4E-DCBD4D3ABEF2

Q56964366-0C9581C9-3C61-4454-9A5C-6CE8810A7239

Q56964366-1CD34C81-9FA5-4FB7-B51C-8EFB393A04F5

Q56964366-3F0275F3-91A3-4D66-9809-83287285E5AC

Q56964366-3F342A59-7C7D-466D-80F7-D37C90A8E60F

Q56964366-4754F643-D4B5-41D7-B9B7-6B3AD5CD6212

Q56964366-511AB8B0-6614-45E2-8B5F-9506D7A323A4

Q56964366-6D4699F0-5531-4421-9751-8F66CCD12074

Q56964366-834BDC3B-5C00-462B-95E2-84D5F0268030

Q56964366-8A3BF7A5-EF05-4648-B4D7-191D492656B1

P304

Q56964366-014A9CAF-609C-4C73-AC09-BBE7A6DD5177

P31

Q56964366-F3DB27EF-C921-4880-A2B2-32812EF944D4

P356

Q56964366-F24AD81C-62D1-480F-9B38-2F6B0971E919

P407

Q56964366-150ADE60-327A-4C9D-8C4C-47485226FCE1

P433

Q56964366-190A817F-64B8-4859-9B51-8223F177AEF2

P478

Q56964366-758B0D09-C806-42AF-82C2-ACE1FD9DF931

P50

Q56964366-512F1ACF-E5BA-4221-9A4A-396C69285B95

P577

Q56964366-55A9407D-DF4D-4B17-BD71-14CD7742F71C

P698

Q56964366-B21897F5-977A-4CE7-B97E-ADA2F80BA333

P921

Q56964366-79C7CADC-E4AA-4A92-85B0-90280DA65F8D

P356

P1433

Journal of Biological Chemistry

P1476

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

@en

P2093

Cecilia M. Giachelli

http://www.w3.org/2001/XMLSchema#string

Katherine L. Suchland

http://www.w3.org/2001/XMLSchema#string

Marta Scatena

http://www.w3.org/2001/XMLSchema#string

Theodore J. Yun

http://www.w3.org/2001/XMLSchema#string

Uriel M. Malyankar

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

The NF-kappa B and I kappa B proteins: new discoveries and insights

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1

NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

P304

20959-20962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.C000290200

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

275

http://www.w3.org/2001/XMLSchema#string

P50

Edward A. Clark

P577

2000-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10811631

http://www.w3.org/2001/XMLSchema#string

P921